Abstract:Yunning Huang, 1, * Yuanyuan Yang, 2, * Yuanyi Xu, 2, * Qian Ma, 3, 4, * Fengying Guo, 2 Yuan Zhao, 2 Yuejia Tao, 2 Mengqi Li, 2 Jiaxin Guo 2 1 Department of Gastrointestinal Surgery, The Affiliated People's Hospital of Ningxia Medical University, Yinchuan City, Ningxia Province, 750001, People's Republic of China; 2 Department of Pathology, Ningxia Medical University, Yinchuan City, Ningxia Province, 750004, People's Republic of China; 3 College of Life Sciences, Ningxia University, Yinchuan City, Ningxia Province, 750021, People's Republic of China; 4 College of Basic Medicine, Ningxia Medical University, Yinchuan City, Ningxia Province, 750004, People's Republic of China *These authors contributed equally to this work Correspondence: Yunning Huang; Yuanyi Xu Email ; Purpose: Gastric cancer (GC) is one of the most fatal digestive tumors worldwide. Abnormal activation or accumulation of the nuclear factor-erythroid 2-related factor 2/heme oxygenase 1 (Nrf2/HO-1) axis is a malignant event in numerous solid tumors. However, its involvement in angiogenesis of GC remains unknown. This study investigated the role of the Nrf2/HO-1 axis in angiogenesis of GC. Methods: The expression of Nrf2, HO-1, and vascular endothelial growth factor (VEGF) in BGC-823 cells under hypoxia was analyzed using immunocytochemistry, immunofluorescence, Western blotting, and quantitative polymerase chain reaction. The effects of brusatol (Nrf2 inhibitor) and tert-butylhydroquinone (Nrf2 inducer) on these factors and angiogenesis were examined using immunofluorescence, Western blotting, quantitative polymerase chain reaction, and tube formation assay. Moreover, immunohistochemistry and Western blotting were used to determine these factors and microvessel density in tumor and normal tissues of tumor-bearing and tumor-free mice, respectively. Immunohistochemistry and Western blotting were employed to examine these factors and microvessel density in human paracancerous tissues, well-differentiated GC, and poorly differentiated GC. The correlations between Nrf2, HO-1, and VEGF gene expression in 375 patients with GC from The Cancer Genome Atlas cohort were analyzed. Results: The expression of Nrf2, HO-1, and VEGF was increased in hypoxic BGC-823 cells ( P < 0.05). Although brusatol decreased their expression and angiogenesis ( P < 0.05), tert-butylhydroquinone had the opposite effect ( P < 0.05). Moreover, the expression of Nrf2, HO-1, and VEGF, and microvessel density in tumor tissues was higher than that recorded in normal tissues of nude mice ( P < 0.05). Similarly, these parameters were low in paracancerous tissues, but high in GC tissues ( P < 0.05). Also, they were weak in well-differentiated GC, but strong in poorly differentiated GC ( P < 0.05). In addition, there was a significant correlation between Nrf2, HO-1, and VEGF ( P < 0.05). Conclusion: The Nrf2/HO-1 axis may regulate the angiogenesis of GC via targeting VEGF. These findings provide a promising biomarker and potential treatment target for GC. Keywords: gastric cancer, angiogenesis, Nrf2, HO-1, VEGF

Knockdown of Nrf2 Suppresses Glioblastoma Angiogenesis by Inhibiting Hypoxia-Induced Activation of HIF-1α.

Knockdown of NF-E2-related Factor 2 Inhibits the Proliferation and Growth of U251MG Human Glioma Cells in a Mouse Xenograft Model

Knockdown of Nrf2 inhibits angiogenesis by down-regulating VEGF expression through PI3K/Akt signaling pathway in cerebral microvascular endothelial cells under hypoxic conditions.

Silencing Nrf2 Impairs Glioma Cell Proliferation Via AMPK-activated Mtor Inhibition.

Correlation of Nrf2 and HIF-1α in Glioblastoma and Their Relationships to Clinicopathologic Features and Survival

Transcription Factor Nfat5 Promotes Glioblastoma Cell-Driven Angiogenesis Via Sbf2-As1/Mir-338-3p-Mediated Egfl7 Expression Change

The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin

ERK and PI3K Signaling Cascades Induce Nrf2 Activation and Regulate Cell Viability Partly Through Nrf2 in Human Glioblastoma Cells.

Knockdown of Nuclear Factor Erythroid 2-Related Factor 2 by Lentivirus Induces Differentiation of Glioma Stem-Like Cells.

Hypoxic Cancer-Secreted Exosomal Mir-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-Like Factor 2 and 4

Hypoxia-Induced Autophagy Is Involved in Radioresistance via HIF1A-Associated Beclin-1 in Glioblastoma Multiforme

GSH Depletion and Consequent AKT Inhibition Contribute to the Nrf2 Knockdown-Induced Decrease in Proliferation in Glioblastoma U251 Cells.

Hypoxia-inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells.

Silencing of HIF-1α Enhances the Radiation Sensitivity of Human Glioma Growth in Vitro and in Vivo.

Constitutive NF-kappaB Activity Regulates the Expression of VEGF and IL-8 and Tumor Angiogenesis of Human Glioblastoma.

Upregulated AHIF-mediated Radioresistance in Glioblastoma.

Nrf2/HO-1 Axis Regulates the Angiogenesis of Gastric Cancer via Targeting VEGF

Blockage of Nrf2 Suppresses the Migration and Invasion of Esophageal Squamous Cell Carcinoma Cells in Hypoxic Microenvironment.

Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis

Correction To: Nrf2 is Required to Maintain the Self-Renewal of Glioma Stem Cells

The role of nuclear factor erythroid 2-related factor in cell proliferation of human glioma cell U251